• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞充当体内重编程的外在屏障。

Natural killer cells act as an extrinsic barrier for in vivo reprogramming.

机构信息

Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain.

Department of Discovery Oncology, Genentech, South San Francisco, CA 94080, USA.

出版信息

Development. 2022 Apr 15;149(8). doi: 10.1242/dev.200361. Epub 2022 Apr 22.

DOI:10.1242/dev.200361
PMID:35420133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9124575/
Abstract

The ectopic expression of the transcription factors OCT4, SOX2, KLF4 and MYC (OSKM) enables reprogramming of differentiated cells into pluripotent embryonic stem cells. Methods based on partial and reversible in vivo reprogramming are a promising strategy for tissue regeneration and rejuvenation. However, little is known about the barriers that impair reprogramming in an in vivo context. We report that natural killer (NK) cells significantly limit reprogramming, both in vitro and in vivo. Cells and tissues in the intermediate states of reprogramming upregulate the expression of NK-activating ligands, such as MULT1 and ICAM1. NK cells recognize and kill partially reprogrammed cells in a degranulation-dependent manner. Importantly, in vivo partial reprogramming is strongly reduced by adoptive transfer of NK cells, whereas it is significantly increased by their depletion. Notably, in the absence of NK cells, the pancreatic organoids derived from OSKM-expressing mice are remarkably large, suggesting that ablating NK surveillance favours the acquisition of progenitor-like properties. We conclude that NK cells pose an important barrier for in vivo reprogramming, and speculate that this concept may apply to other contexts of transient cellular plasticity.

摘要

转录因子 OCT4、SOX2、KLF4 和 MYC(OSKM)的异位表达可将分化细胞重编程为多能胚胎干细胞。基于部分和可逆体内重编程的方法是组织再生和年轻化的有前途的策略。然而,对于在体内环境中阻碍重编程的障碍知之甚少。我们报告称,自然杀伤 (NK) 细胞在体外和体内均显著限制重编程。处于重编程中间状态的细胞和组织上调表达 NK 激活配体,如 MULT1 和 ICAM1。NK 细胞以脱颗粒依赖性方式识别和杀死部分重编程的细胞。重要的是,通过 NK 细胞的过继转移,体内部分重编程强烈减少,而其耗竭则显著增加。值得注意的是,在没有 NK 细胞的情况下,源自表达 OSKM 小鼠的胰腺类器官显著增大,表明消除 NK 监视有利于获得祖细胞样特性。我们得出结论,NK 细胞是体内重编程的一个重要障碍,并推测这一概念可能适用于其他短暂细胞可塑性的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/4d3f794097bc/develop-149-200361-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/49bc15f9f22e/develop-149-200361-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/a25ad387cddd/develop-149-200361-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/f9178fbe71f1/develop-149-200361-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/599d095e1f6c/develop-149-200361-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/f0ecfa74ba25/develop-149-200361-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/84753b9914b7/develop-149-200361-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/4d3f794097bc/develop-149-200361-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/49bc15f9f22e/develop-149-200361-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/a25ad387cddd/develop-149-200361-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/f9178fbe71f1/develop-149-200361-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/599d095e1f6c/develop-149-200361-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/f0ecfa74ba25/develop-149-200361-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/84753b9914b7/develop-149-200361-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/9124575/4d3f794097bc/develop-149-200361-g7.jpg

相似文献

1
Natural killer cells act as an extrinsic barrier for in vivo reprogramming.自然杀伤细胞充当体内重编程的外在屏障。
Development. 2022 Apr 15;149(8). doi: 10.1242/dev.200361. Epub 2022 Apr 22.
2
Deciphering the roadmap of in vivo reprogramming toward pluripotency.解析体细胞核重编程为多能性的路线图。
Stem Cell Reports. 2022 Nov 8;17(11):2501-2517. doi: 10.1016/j.stemcr.2022.09.009. Epub 2022 Oct 20.
3
A Versatile In Vivo System to Study Myc in Cell Reprogramming.一种用于研究 Myc 在细胞重编程中的多功能体内系统。
Methods Mol Biol. 2021;2318:267-279. doi: 10.1007/978-1-0716-1476-1_14.
4
Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.多能性重编程因子与基因组初始结合的促进因素和阻碍因素。
Cell. 2012 Nov 21;151(5):994-1004. doi: 10.1016/j.cell.2012.09.045. Epub 2012 Nov 15.
5
OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.OSKM 诱导胚胎外内胚层干细胞与诱导多能干细胞平行分化。
Stem Cell Reports. 2016 Apr 12;6(4):447-455. doi: 10.1016/j.stemcr.2016.02.003. Epub 2016 Mar 3.
6
Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.部分重编程细胞向完全多能干细胞的转化与干细胞维持和配子生成相关基因的进一步激活有关。
Stem Cells Dev. 2014 Nov 1;23(21):2637-48. doi: 10.1089/scd.2014.0020. Epub 2014 Aug 20.
7
Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.分子层面深入了解 OSKM 基因调控网络介导的重编程起始事件。
PLoS One. 2011;6(8):e24351. doi: 10.1371/journal.pone.0024351. Epub 2011 Aug 31.
8
Roadmap of the Early Events of Somatic Cell Reprogramming.体细胞重编程早期事件的路线图。
Cell Reprogram. 2023 Feb;25(1):7-8. doi: 10.1089/cell.2022.0160. Epub 2023 Jan 25.
9
Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.Sox2 和 Klf4 作为无外源 Oct4 诱导多能性的功能核心。
Cell Rep. 2019 Nov 12;29(7):1986-2000.e8. doi: 10.1016/j.celrep.2019.10.026.
10
Reprogramming in vivo produces teratomas and iPS cells with totipotency features.重编程体内产生畸胎瘤和具有全能性特征的 iPS 细胞。
Nature. 2013 Oct 17;502(7471):340-5. doi: 10.1038/nature12586. Epub 2013 Sep 11.

引用本文的文献

1
Refined cell transfer model reveals roles for Ascl2 and Cxcr3 in splenic localization of mouse NK cells during virus infection.优化的细胞转移模型揭示了在病毒感染期间Ascl2和Cxcr3在小鼠自然杀伤细胞脾脏定位中的作用。
J Immunol. 2025 Jul 22. doi: 10.1093/jimmun/vkaf122.
2
Identification of Grb2 protein as a potential mediator of macrophage activation in acute pancreatitis based on bioinformatics and experimental verification.基于生物信息学和实验验证鉴定Grb2蛋白为急性胰腺炎中巨噬细胞活化的潜在介质。
Front Immunol. 2025 May 26;16:1575880. doi: 10.3389/fimmu.2025.1575880. eCollection 2025.
3
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications.

本文引用的文献

1
Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice.心肌细胞向胎儿状态的可逆重编程可驱动小鼠的心脏再生。
Science. 2021 Sep 24;373(6562):1537-1540. doi: 10.1126/science.abg5159. Epub 2021 Sep 23.
2
NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.NKG2D 自然杀伤细胞受体——简要描述及潜在的临床应用。
Cells. 2021 Jun 7;10(6):1420. doi: 10.3390/cells10061420.
3
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
OCT4在肿瘤微环境中的多方面作用:生物学及治疗意义
Oncogene. 2025 May;44(18):1213-1229. doi: 10.1038/s41388-025-03408-x. Epub 2025 Apr 14.
4
The occurrence and development of induced pluripotent stem cells.诱导多能干细胞的发生与发展。
Front Genet. 2024 Apr 18;15:1389558. doi: 10.3389/fgene.2024.1389558. eCollection 2024.
5
Vitamin B emerges as key player during cellular reprogramming.维生素B在细胞重编程过程中成为关键因素。
Nat Metab. 2023 Nov;5(11):1844-1845. doi: 10.1038/s42255-023-00917-5.
6
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging.酪氨酸激酶抑制剂达沙替尼的免疫调节活性,以引发自然杀伤细胞对癌症、HIV感染和衰老的细胞毒性。
Pharmaceutics. 2023 Mar 11;15(3):917. doi: 10.3390/pharmaceutics15030917.
7
Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases.细胞衰老的研究:疾病的分子机制和潜在的治疗干预措施。
Signal Transduct Target Ther. 2023 Mar 14;8(1):116. doi: 10.1038/s41392-023-01343-5.
8
Integration of scRNA-Seq and Bulk RNA-Seq Reveals Molecular Characterization of the Immune Microenvironment in Acute Pancreatitis.单细胞 RNA 测序和批量 RNA 测序的整合揭示了急性胰腺炎免疫微环境的分子特征。
Biomolecules. 2022 Dec 30;13(1):78. doi: 10.3390/biom13010078.
9
Age reprogramming: cell rejuvenation by partial reprogramming.年龄重编程:通过部分重编程实现细胞 rejuvenation。
Development. 2022 Nov 15;149(22). doi: 10.1242/dev.200755. Epub 2022 Nov 16.
10
Deciphering the roadmap of in vivo reprogramming toward pluripotency.解析体细胞核重编程为多能性的路线图。
Stem Cell Reports. 2022 Nov 8;17(11):2501-2517. doi: 10.1016/j.stemcr.2022.09.009. Epub 2022 Oct 20.
自然杀伤细胞与肿瘤微环境中的髓系来源抑制细胞的相互作用及其对癌症免疫治疗的影响。
Front Immunol. 2021 May 5;12:633205. doi: 10.3389/fimmu.2021.633205. eCollection 2021.
4
Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT.实体瘤和血液系统恶性肿瘤中骨髓来源抑制细胞与自然杀伤细胞的相互作用:对 HSCT 的影响。
Front Immunol. 2021 Feb 12;12:638841. doi: 10.3389/fimmu.2021.638841. eCollection 2021.
5
SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data.SoupX 去除了基于液滴的单细胞 RNA 测序数据中的环境 RNA 污染。
Gigascience. 2020 Dec 26;9(12). doi: 10.1093/gigascience/giaa151.
6
Reprogramming to recover youthful epigenetic information and restore vision.重编程以恢复年轻的表观遗传信息并恢复视力。
Nature. 2020 Dec;588(7836):124-129. doi: 10.1038/s41586-020-2975-4. Epub 2020 Dec 2.
7
Going up the hill: chromatin-based barriers to epigenetic reprogramming.上山之路:基于染色质的表观遗传重编程障碍。
FEBS J. 2021 Aug;288(16):4798-4811. doi: 10.1111/febs.15628. Epub 2020 Dec 6.
8
Reprogramming roadmap reveals route to human induced trophoblast stem cells.重编程路线图揭示了人类诱导滋养层干细胞的形成途径。
Nature. 2020 Oct;586(7827):101-107. doi: 10.1038/s41586-020-2734-6. Epub 2020 Sep 16.
9
Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status.中性粒细胞在转移性定植中的双重作用受宿主 NK 细胞状态的控制。
Nat Commun. 2020 Sep 1;11(1):4387. doi: 10.1038/s41467-020-18125-0.
10
Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine.去分化:再生医学工程策略设计的灵感来源
NPJ Regen Med. 2020 Jul 31;5:14. doi: 10.1038/s41536-020-00099-8. eCollection 2020.